Global Endometrial Cancer Therapeutics Market Projections, SWOT Analysis, Risk Analysis, Trends and Forecast by 2023 – Market Research Report 2017 has published new research report on "Global Endometrial Cancer Therapeutics Market Research Report and Forecast to 2017-2023" to its database.

Dallas, United States - July 17, 2017 /MarketersMedia/ —

Endometrial Carcinoma is a common form of cancer of the female reproductive system that initiates in the lining of the uterus. According to the American Cancer Society, endometrial cancer is also the most common cancer of the female reproductive organs in the US. About 60,050 new cases of cancer of uterus were estimated to be diagnosed during 2016, and about 10,470 women died from cancers of the uterine body during the same year.Early detection of endometrial cancer helps in the selection of proper treatment options. Endometrial Cancer can be treated by one or combination of therapies, such as chemotherapy, radiation therapy, hormone therapy, and surgery. Most of the physicians generally recommend combination treatments because chemotherapy alone has conventionally been deemed ineffective. Furthermore, adjuvant radiation therapy is ideal in patients who have diagnosed with Stage I or II endometrial cancer. Radiation Therapy is also recommended in patients who have undergone the surgery to avoid the relapse of endometrial cancer.

Browse the report:

According to the RNCOS report entitled “Global Endometrial Cancer Therapeutics Market By Therapy (Chemotherapy, Hormone Therapy, Radiation Therapy, Surgery), By Enduser (Research Institutes, Hospitals & Clinics), & Pipeline Analysis, Outlook to 2023”, the Endometrial Cancer therapeutics market is poised to reach approximately US$ 27 Billion by 2023. In this report, there is in-depthmarket analysis as well as market segmentation of global endometrial cancer therapeutics. The market potential of endometrial cancer therapeutic drugsisestimated considering that these are being tested in clinical trials for endometrial cancer, besides the ones which have already been approved. The depictedendometrial cancer therapeutic drugsare expected to show their complete market potential soon in the coming years.

Furthermore, in this report we have structured the information on epidemiology of endometrial cancer in the world. The report also covers pipeline analysis of endometrial cancer therapeutic drugs at various stages of clinical development that are under research or in collaboration, and those individually being developed by companies. Moreover, our report places an emphasis on the major drivers and challenges, latest trends and developments,as well as strategic collaborations that can impact industry’s growth.

Request a sample of the report:

In the end, the report enlists some of the key players in the Endometrial Cancer Therapeutics market including business overview of each player along with their product and pipeline portfolios, recent developments, and comparative analysis of their strengths and weaknesses.Conclusively, the report will prove to be a complete and comprehensive source of knowledge and analysis for clients and potential investors or debut makers in this industry.

Major Points From The Table Of Contents:
Analyst View
Research Methodology
Endometrial Cancer - Epidemiology & Risk Factors
Endometrial Cancer Therapeutics - An Introduction
Market Dynamics
Endometrial Cancer Therapeutics Market Outlook to 2023
Market Segmentation
Endometrial Cancer Therapeutic Drugs Pipeline Analysis
Trends and Developments
Strategic Mergers & Collaborations in the Endometrial Cancer Therapeutics Industry
Competitive Assessment

Buy the report@

List of Figures:
Figure 3-1: Estimated Age-specific Incidence & Mortality Rates for Endometrial Cancer, 2016
Figure 4-1: Endometrial Cancer Therapeutic Drugs - Mechanism of Action
Figure 5-1: Global Healthcare Spending (Billion US$), 2015 & 2020
Figure 5-2: Healthcare Spending by Region (Billion US$), 2015 & 2020
Figure 6-1: Global - Endometrial Cancer Therapeutics Market (Billion US$), 2016-2023
Figure 7-1: Global - Endometrial Cancer Therapeutics Market by Therapy (%), 2016
Figure 7-2: Global - Endometrial Cancer Chemotherapy Market (Billion US$), 2016 & 2023
Figure 7-3: Global - Endometrial Cancer Hormone Therapy Market (Billion US$), 2016 & 2023
Figure 7-4: Global - Endometrial Cancer Radiation Therapy Market (Billion US$), 2016 & 2023
Figure 7-5: Global - Endometrial Cancer Surgery Market (Billion US$), 2016 & 2023
Figure 7-6: Global - Endometrial Cancer Therapeutics Market by End Users (%), 2016
Figure 7-7: Global - Endometrial Cancer Therapeutics Market by Research Institutes (Billion US$), 2016 & 2023
Figure 7-8: Global - Endometrial Cancer Therapeutics Market by Hospitals (Billion US$), 2016 & 2023

List of Tables:
Table 6-1: Potential Patients for Endometrial Cancer Therapeutics, 2015, 2020 & 2025
Table 8-1: Industrial Endometrial Cancer Therapeutic Drugs Pipeline
Table 8-2: Research Collaborations Endometrial Cancer Therapeutic Drugs Pipeline
Table 10-1: Strategic Mergers & Collaborations in Endometrial Cancer Therapeutics Industry, 2014-2016
Table 11-1: Top Companies by Endometrial Cancer Therapeutic Drugs in Pipeline (2016)
Table 11-2: Bayer AG - Endometrial Cancer Therapeutic Drugs in Pipeline
Table 11-3: Bayer AG - Key Financials (Million US$), 2014-2016
Table 11-4: F. Hoffman La Roche Ltd. - Endometrial Cancer Therapeutic Drugs in Pipeline
Table 11-5: F. Hoffman La Roche Ltd. - Key Financials (Million US$), 2014-2016

About Us:
Orbis Research ( is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Info:
Name: Hector Costello
Organization: Orbis Research
Address: 4144N Central Expressway, Suite 600, Dallas, Texas – 75204, U.S.A.
Phone: +1 (214) 884-6817

Source URL:

For more information, please visit

Source: MarketersMedia

Release ID: 217971

Latest News

New Bollywood film tackles taboo of menstrual hygiene

Feb 18, 2018

NEW DELHI — It's an unlikely scene in deeply conservative India: A hugely popular Bollywood male star grinning widely as he holds up a sanitary pad and talks of menstrual hygiene. But that's exactly what action hero Akshay Kumar did as he promoted his film "Padman," which opened in theaters Friday. Kumar plays the lead role of a man who starts manufacturing inexpensive sanitary pads after he discovers his wife's lack of access to them in a small town in southern India. The subject of menstruation and menstrual hygiene is rarely, if ever, discussed openly in Indian homes. At pharmacies...

Rescued French climber leaves Pakistan after peak tragedy

Feb 18, 2018

ISLAMABAD — A mountain climber who was rescued from a Himalayan peak where her climbing partner is presumed to have died has returned home to France, a representative of a Pakistani mountaineering group said Tuesday. Karrar Haidri of the Alpine Club of Pakistan said Elisabeth Revol left Pakistan before dawn. Revol praised everyone who participated in rescuing her from Nanga Parbat, said Haidri, who visited her at the Islamabad where she was treated. Suffering from frostbite and exhaustion, Revol was rescued Sunday by Polish climbers who were on a separate expedition and braved high winds and low nighttime temperatures to...

Rescued French climber recovering in Pakistani hospital

Feb 18, 2018

ISLAMABAD — A French climber rescued from a Himalayan peak is recovering and will soon return home, Pakistani officials said. Elisabeth Revol, suffering from frostbite and exhaustion, was rescued by volunteers from a separate Polish expedition on Sunday from Nanga Parbat, also known as "killer mountain." She was airlifted to Islamabad and was being treated at the Shifa International Hospital. Karrar Haidri, a senior official in the Pakistan Alpine Federation who visited her in the hospital, said she would be discharged within hours and head home early Tuesday. The search for Revol's fellow climber, Polish national Tomasz Mackiewicz, was called...

The Latest: Trump condemns car bomb attack in Afghanistan

Feb 18, 2018

KABUL, Afghanistan — The Latest on a deadly explosion caused by a suicide bomber driving an ambulance in Afghanistan (all times local): 2:35 a.m. President Donald Trump is condemning "the despicable car bombing attack" in the Afghan capital of Kabul that has killed at least 95 people and wounded 158 more. He says "all countries should take decisive action" against the Taliban, which has claimed responsibility for Saturday's attack. Trump says the "murderous attack" renews the U.S. resolve with its Afghan partners. He says, "The Taliban's cruelty will not prevail" and the U.S. is "committed to a secure Afghanistan that...

India, Cambodia to expand ties in IT, infrastructure sectors

Feb 18, 2018

NEW DELHI — The leaders of India and Cambodia on Saturday agreed to work toward a bilateral investment treaty that could see tens of millions of dollars pour into the Southeast Asian nation. The meeting between Cambodian Prime Minister Hun Sen and Indian Prime Minister Narendra Modi saw Cambodia invite Indian investment in information technology, pharmaceuticals, agriculture and horticulture, infrastructure and small and medium enterprises. A broader treaty will take time but India agreed to provide lines of credit, including nearly $37 million to finance a Cambodian water project. India also offered lines of credit for setting up specialty hospitals,...

Sign up now!

Recent Discovery will take you to the captivating developments in science, technology, and the universe around us. We deliver to you the latest news, theories, and developments in the world of science.

Contact us: